Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Billich

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Entecavir (Bristol-Myers Squibb)A Billich
Idrugs : the Investigational Drugs Journal|May 10, 2008
GS-4104 Gilead Sciences IncA Billich
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: FluMist, University of MichiganA Billich
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Pleconaril Sanofi Synthélabo/ViroPharmaA Billich
Idrugs : the Investigational Drugs Journal|September 13, 2005
Amprenavir (Vertex Pharmaceuticals Inc)A Billich
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001
AIDSVAX. VaxGenA Billich
The Journal of Biological Chemistry|December 25, 1987
Enzymatic synthesis of cyclosporin AA Billich, R Zocher
Peptide Research|November 1, 1990
Colorimetric assay of HIV-1 proteinase suitable for high-capacity screeningA Billich, G Winkler
Archiv Der Pharmazie|March 12, 1999
Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitorsA Hilgeroth, A Billich
Applied and Environmental Microbiology|October 1, 1988
Constitutive Expression of Enniatin Synthetase during Fermentative Growth of Fusarium scirpiA Billich, R Zocher
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2001
Entecavir (Bristol-Myers Squibb)A Billich
Idrugs : the Investigational Drugs Journal|May 10, 2008
GS-4104 Gilead Sciences IncA Billich
Current Opinion in Molecular Therapeutics|March 16, 2001
Technology evaluation: FluMist, University of MichiganA Billich
Current Opinion in Investigational Drugs (London, England : 2000)|March 16, 2001
Pleconaril Sanofi Synthélabo/ViroPharmaA Billich
Idrugs : the Investigational Drugs Journal|September 13, 2005
Amprenavir (Vertex Pharmaceuticals Inc)A Billich
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2001
AIDSVAX. VaxGenA Billich
The Journal of Biological Chemistry|December 25, 1987
Enzymatic synthesis of cyclosporin AA Billich, R Zocher
Peptide Research|November 1, 1990
Colorimetric assay of HIV-1 proteinase suitable for high-capacity screeningA Billich, G Winkler
Archiv Der Pharmazie|March 12, 1999
Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitorsA Hilgeroth, A Billich
Applied and Environmental Microbiology|October 1, 1988
Constitutive Expression of Enniatin Synthetase during Fermentative Growth of Fusarium scirpiA Billich, R Zocher
Pageof 5